Sucampo Pharma Balance Sheet - Quarterly (NASDAQ:SCMP)

Add to My Stocks
$18 $0 (0%) SCMP stock closing price Feb 13, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Sucampo Pharma, and helps in stock analysis. As in our Sucampo Pharma stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. A company releases its balance sheet every quarter along with its quarterly results. The Sucampo Pharma balance sheet for 2017 Q3 shows total assets of $388.14M. The company has a asset turnover ratio of 0.65. Also see: Sucampo Pharma revenue and Sucampo Pharma operating cash flow for the same quarter.

View and download Sucampo Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Marketable Securities--------
Raw Materials-3.65M3.31M1.41M2.37M-1.69M5.55M
Work In Progress21.72M19.4M18.13M18.04M20.38M19.56M21.67M26.92M
Finished Goods1.66M-1.52M4M1.45M1.68M1.06M-
Notes Receivable--------
Other Current Assets34.73M16.72M16.72M15.98M18.14M24.32M14.09M9.18M
Total Current Assets
Property Plant & Equipment---9.94M---9.97M
Accumulated Depreciation---3.72M---3.57M
Net Property Plant & Equipment
Investment & Advances10.69M5.61M5.55M5.49M----
Other Non-Current Assets----5.18M5.11M5M-
Deferred Charges----1.4M1.4M1.4M1.4M
Deposits & Other Assets----1.03M7.99M7.35M6.77M
Total Assets
Notes Payable39.08M8.24M26.89M19.12M20.4M19.52M--
Accounts Payable6.24M11.17M8M9.19M7.86M6.16M5.13M11.21M
Current Portion Long-Term Debt--------
Current Portion Capital Leases--------
Accrued Expenses15.12M12.69M19.63M12.38M14.38M13.29M13.68M10.88M
Income Taxes Payable9.66M4.38M3.47M7.15M16.58M6.27M3.46M6.5M
Other Current Liabilities6.14M3.86M3.71M3.61M6.24M8.21M12.29M20.43M
Total Current Liabilities
Deferred Taxes/Income9.96M5.77M19.94M22.09M42.67M69.5M60.12M53.58M
Convertible Debt--------
Long-Term Debt291.94M291.45M290.97M290.51M196.98M202.41M207.86M213.27M
Non-Current Capital Leases--------
Other Long-Term Liabilities9.41M9.39M9.14M8.79M8.29M18.42M16.95M15.74M
Total Liabilities
Minority Interest--------
Preferred Stock--------
Common Stock Net--------
Capital Surplus130.1M127.2M123.98M120.25M113.44M105.13M102.11M99.21M
Retained Earnings-141.37M-151.74M41.67M38.12M22.84M14.75M15.58M19.63M
Treasury Stock4.01M4.01M46.26M46.26M46.26M46.26M46.26M46.26M
Other Liabilities54.45M54.43M54.45M54.52M54.33M49.69M28.95M13.41M
Shareholders Equity39.63M26.34M174.3M167.09M144.81M123.76M100.84M86.44M
Total Liabilities & Shareholders Equity388.14M365.08M529.2M520.85M459.56M469.74M448.21M457.18M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Most investors just check the Sucampo Pharma stock price, and Sucampo Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Sucampo Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: SCMP total assets, which was at $388.14M for 2017 Q3 is a balance sheet item representing value of what Sucampo Pharma owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. SCMP stock had total liabilities of $348.51M for the quarter 2017 Q3.

Sucampo Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio